期刊文献+

MR灌注成像在肝细胞癌中的研究进展 被引量:1

Advance of MR Perfusion Imaging in Hepatocellular Carcinoma
在线阅读 下载PDF
导出
摘要 肝细胞癌是肝硬化患者死亡的最常见原因,常规磁共振成像只能获得肝细胞癌的解剖信息,而MR灌注成像是利用快速成像技术和图像后处理技术来反映组织内的微血管分布及灌注情况,从而对肿瘤进行早期诊断及疗效评估。本文将围绕MR灌注成像在肝细胞癌的诊断及预后评估中的研究与应用开展综述。 Hepatocellular carcinoma is the most common cause of death in patients with cirrhosis.Conventional magnetic resonance imaging can only be used to obtain anatomical information of hepatocellular carcinoma,while MR perfusion imaging with rapid imaging technology and image post-processing techniques can be used to reflect the distribution of micro-vessels in tissues,which allows early diagnosis and evaluation of the tumor.This article will review the research and application of MR perfusion imaging in the diagnosis and prognosis of hepatocellular carcinoma.
作者 王璐娜 李若坤 强金伟 WANG Lu-na;LI Ruo-kun;QIANG Jin-wei(Department of Radiology,Jinshan Hospital,Fudan University,Shanghai 200025;Department of Radiology,Ruijin Hospital,Shanghai Jiaotong University of Medicine)
出处 《中国医学计算机成像杂志》 CSCD 北大核心 2020年第1期85-88,共4页 Chinese Computed Medical Imaging
基金 国家自然科学基金No.81501433。
关键词 肝细胞癌 MR灌注成像 诊断 预后评估 Hepatocellular carcinoma MR perfusion imaging Diagnosis Prognosis assessment
  • 相关文献

参考文献1

二级参考文献25

  • 1卢光明,杨刚,张福琛,沈复兴,王昌新.动态增强MRI诊断垂体微腺瘤的研[J].中华放射学杂志,1996,30(5):329-332. 被引量:39
  • 2Runge VM, Clanton JA, Herzer WA, et al. Intravascular contrast agents suitable for magnetic resonance imaging[J]. Radiology, 1984,153(1): 171-176.
  • 3Dujardin MI, Sourbron SP, Chaskis C, et al. Quantification of cerebral tumour blood flow and permeability with T,- weighted dynamic contrast enhanced MRI: a feasibility study [J].J Neuroradiol, 2012, 39(4):227-235.
  • 4Johnson G, Wetzel SG, Cha S, et al. Measuring blood volume and vascular transfer constant from dynamic, T(2)" - weighted contrast -enhancet~lRI[J].MagnResonMed,200431 (5):961-968.
  • 5Agner SC, Rosen MA, Englander S, et al. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study[J].Radiology, 2014, 272(1):91-99.
  • 6Nci C. MR workshop on translational research in cancer: recommendations for MR measurement methods at 1.5-Tesla and endpoints for use in phase 1/2a trials of anti- cancer therapeutics affecting tumor vascular function[R]. Maryland: National Cancer Institute, National Institutes of Health, 2008:1-10.
  • 7Tofts PS, Kermode AG. Measurement of the blood- brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts[J].Magn Reson Med, 1991, 17(2):357-367.
  • 8van Lin EN, Fiitterer JJ, Heijmink SW, et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker- based three-dimensional fusion of CT with dynamic contrast- enhanced and 1H-spectroscopic MRI[J]. Int J Radiat Oncol Biol Phys,2006,65(1):291-303.
  • 9Yang Q, Li L, Zhang J, et al. A new quantitative image analysis method for improving breast cancer diagnosis using DCE-MRI examinations[J].Med Phys, 2015, 42(1):103-109.
  • 10Schaeht DV, Drukker K, Pak I, et al. Using quantitative image analysis to classify axillary lymph nodes on breast MRI: a new application for the Z 0011 Era[J].Eur J Radiol, 2015, 84(3):392-397.

共引文献45

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部